Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, and Chronic Lymphocytic Leukemia [Phase 1]
Phase 1 trial evaluating TriCAR19.20.22 T cells, a CD19/20/22-targeting CAR-T therapy, for relapsed or refractory non-Hodgkin lymphoma, acut…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
This clinical trial update describes biospecimen procurement for the Center for Immuno-Oncology immunotherapy protocols. It covers recruitin…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 clinical trial evaluating CAR-T cell therapy for HIV-infected individuals with AIDS-related and other B-cell non-Hodgkin lymphomas; …
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating BMS-986458 alone and in combination with anti-lymphoma agents for relapsed or refractory Non-Hodgkin l…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma [Phase 2]
A Phase 2 trial is evaluating an Ibrutinib-based combination therapy for newly diagnosed primary central nervous system lymphoma in transpla…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy, safety, and pharmacokinetics of XEMBIFY plus standard medical treatment (SMT) versus pl…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas [Phase 1]
Phase 1 clinical trial update for constitutive IL7R (C7R) modified banked allogeneic CD30.CAR EBVSTs in CD30-positive lymphomas, currently r…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]
This document provides a status update on a Phase 1/2 clinical trial evaluating JNJ-90014496 in participants with B-cell non-Hodgkin lymphom…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) [Phase 1]
A Phase 1 study of JNJ-80948543, a T-cell redirecting trispecific antibody, in Non-Hodgkin lymphoma and chronic lymphocytic leukemia, is cur…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003) [Phase 2]
Phase 2 trial update on the efficacy and safety of Nemtabrutinib (MK-1026) in hematologic malignancies, including Waldenström macroglobuline…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies [Phase 1, Phase 2]
AstraZeneca is evaluating AZD0486 as a monotherapy or in combination with other anticancer agents for mature B-cell malignancies in Phase 1/…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: KSV01 Injection for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma [Phase 1]
Phase 1 clinical trial update for KSV01 injection in relapsed/refractory diffuse large B-cell lymphoma (DLBCL) and non-Hodgkin lymphoma; tri…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial [NA]
Clinical trial evaluating whether interrupting sedentary time can improve cardiometabolic health and chemotherapy-related toxicity in patien…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL) [Phase 1]
This is a Phase 1 trial update evaluating JNJ-80948543 in combination with other CD3 T-cell engagers for relapsed or refractory B-cell non-H…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) [Phase 2]
This update reports on a Phase 2 pediatric MATCH trial evaluating ensartinib for patients with relapsed or refractory ALK- or ROS1-genomic a…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Prospective collection, storage, and reporting of data on patients undergoing hematopoietic stem cell transplantation using a standard prepa…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation [NA]
This entry notes a clinical trial exploring an eHealth mindfulness-based music therapy intervention for patients undergoing stem cell transp…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies [Phase 1]
A Phase 1 clinical trial of JNJ-95566692 in participants with non-Hodgkin lymphoid malignancies, with the study currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating adverse events and changes in disease activity of subcutaneous epcoritamab in combination with oral and in…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
A multicenter protocol to improve access and distribution of unlicensed cryopreserved cord blood units, with the study currently recruiting.…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study update for JNJ-88998377 in relapsed/refractory B-cell non-Hodgkin lymphoma; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008) [Phase 1, Phase 2]
This is a Phase 1/2 clinical study of MK-1045 for non-Hodgkin lymphoma, including follicular lymphoma and diffuse large B-cell lymphoma, wit…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation [EARLY_Phase 1]
This early-phase 1 clinical trial investigates CAR19BCMA CAR-T cells for relapsed or refractory plasma cell neoplasms and lymphomas/leukemia…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia. [Phase 1]
Arovella Therapeutics reports a Phase 1 study of ALA-101 in CD19-positive Non-Hodgkin lymphoma and leukemia; the trial is not yet recruiting…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas [Phase 2]
Phase 2 clinical trial evaluating nivolumab in Epstein-Barr virus–positive lymphoproliferative disorders and EBV-positive non-Hodgkin lympho…